progress significant improvements opioid vaccine development recent decades says ivan montoya acting director division therapeutics medical consequences national institute drug abuse nida newer vaccines able stimulate immune system efficiently says production antibodies better past historically holdup not technology vaccine development notes relatively effective medication assisted interventions like methadone opioid vaccine research burner relatively recently right opioid crisis issue going interventions says noting medications not available completely effective option immediate promise vaccine candidates introducing options treat withdrawal symptoms montoya says fda currently reviewing treatment lofexidine approved u.k. hopefully approved u.s. soon says drug partly supported nida developed specifically treatment opioid withdrawal